Core Insights - The company, Qianhai Health (00911), reported a mid-year revenue of approximately HKD 341 million for 2025, reflecting a year-on-year growth of 11.04% [1] - Despite the revenue increase, the net profit decreased to HKD 4.774 million, representing a significant decline of 69.3% compared to the previous period [1] - Earnings per share were reported at HKD 0.0282 [1] Financial Performance - Revenue for the mid-year period reached approximately HKD 341 million, marking an 11.04% increase year-on-year [1] - Gross profit fell from approximately HKD 42.9 million in the previous period to about HKD 14.2 million, indicating a substantial decline [1] - The decrease in gross profit is attributed to intensified market competition, which compelled the company to sell electronic components at lower profit margins [1]

Group 1 - The core viewpoint of the article is that Qianhai Health (00911) reported a revenue increase of approximately HKD 341 million for the first half of 2025, reflecting a year-on-year growth of 11.04% [1] - Despite the revenue growth, the company's net profit decreased to HKD 4.774 million, representing a significant year-on-year decline of 69.3% [1] - The gross profit for the period fell from approximately HKD 42.9 million in the previous period to about HKD 14.2 million, primarily due to intensified market competition leading to lower gross margins on electronic component sales [1]